Google DeepMind CEO reveals Chinese AI models trail Western capabilities by mere months rather than years, though China still lacks breakthrough innovation capacity and faces major obstacles from U.S. chip export bans and significantly smaller computing infrastructure.
NVIDIA launches a $1 billion AI drug discovery lab with pharmaceutical giant Lilly and expands its BioNeMo platform, partnering with major life sciences companies to automate scientific discovery through AI models that predict molecular structures and connect digital agents to robotic laboratory systems.
OpenAI partners with Foxconn to launch 'Sweetpea,' an AirPod-style AI assistant with 2nm processor, targeting 40-50 million units in first year with September release as CEO Sam Altman expands beyond AI models into hardware to directly compete with Apple's dominance.
OpenAI develops 'Sweetpea,' a revolutionary behind-the-ear wearable device featuring skin contact sensors and ultrasonic transmitters that can listen and sense beyond traditional audio capabilities, with Foxconn manufacturing planned for Vietnam indicating serious consumer-scale ambitions.
DeepSeek introduces revolutionary 'Engram' memory technique that bypasses GPU constraints to dramatically expand AI model parameters, potentially helping China overcome hardware limitations while improving performance on industry benchmarks.
OpenAI CEO Sam Altman declares Apple the company's primary long-term competitor, asserting that future AI battles will be won through devices rather than software alone, signaling a strategic shift toward hardware integration for market dominance.
Tesla accelerates Cybercab autonomous vehicle testing with high-speed highway trials and cold weather validation in Buffalo, targeting production start in April and commercial deployment by late 2026.
NVIDIA and Eli Lilly unveil a groundbreaking $1 billion AI co-innovation lab that promises to revolutionize drug discovery by creating a continuous learning system connecting physical laboratories with computational AI for round-the-clock experimentation and pharmaceutical development.
NVIDIA researchers unveil TTT-E2E, a revolutionary AI method that compresses million-token contexts into model weights, delivering 35x faster processing speeds for massive datasets while maintaining constant inference times regardless of context length.
Revolutionary AI-powered exoskeletons weighing under 4.4 pounds break the $1,000 barrier, targeting hikers and seniors as companies push for mainstream adoption like smartwatches, with one manufacturer already selling 20,000 units of the terrain-adapting devices.